I also see that hgen is collaborating with the dep
Post# of 148152
As for the data, my guess is after reading the FDA interim data rules(a post I had a while ago contained this) this excerpt
"Recommendations
for modifications are best accompanied by the minimum amount of data
required for the sponsor to make a reasoned decision about the
recommendation"
Read More: https://investorshangout.com/post/view?id=593...z6d1gE4xWS
I think because enrollment was changed they were given the reason why. I see nothing more detailed than that. Cydys didn't change, although they did recommend adding the 42 day timeline as an additional point of interest. If no changes probably no data.